Consequently, this evidence suggests that HMGCR inhibition enhances CD8+ T cell infiltration and cytotoxicity through cGAS–STING activation, leading to robust anti-tumor immunity and increased sensitivity of colon cancer cells to radiotherapy. Here, HMGCR is linked to neoplasm.